Jonathan Chainey is an Executive Director and Global Head, Data Standards & Governance within Data Sciences, Product Development at Roche. He leads a global team accountable for the cross-functional governance and adoption of Roche’s CDISC-aligned global data standards across all Roche sponsored early & late phase clinical trials. He is currently serving on CDISC’s board of directors and is chair of CDISC’s Technical Advisory Committee.
Over the past 25 years Jonathan has worked within the biopharmaceutical industry in the U.K., Switzerland, and United States. in a range of disciplines including pre-clinical pharmacological research (Ciba-Geigy), clinical data management (Parexel), statistical programming & analysis (Pfizer, Novartis), applications development (Pfizer, Roche), and process analysis, data standards & governance (Roche).
Jonathan has a scientific background and education including a BSc (Hons) Pharmacology, University of Bath, U.K. He is a British citizen and currently located in the San Francisco Bay Area, California.
Prior to joining Citrine Informatics as a Senior Solutions Engineer, Dr. Mark Sullivan spent four years with Dow’s Reaction Engineering group within the Core R&D function, where he worked on both experimental and modeling projects that centered around design, scale-up, and optimization of novel catalytic systems. After studying chemical engineering as an undergraduate at the University of Notre Dame, Mark received his PhD studying the fundamentals of transition metal carbide catalyst systems at the University of Minnesota – Twin Cities under the tutelage of Professor Aditya Bhan, and spent two years as a postdoc working with Professor Yuriy Roman studying zeolite catalysis and electrochemical systems.
Scott Palmese is currently Executive Director, Decentralized Clinical Trials at Worldwide Clinical Trials. He has been in the clinical research industry for almost 15 years and has held a variety of roles in the site and CRO sectors focusing on operations, business development, and strategic direction. Throughout his career, Scott has consistently been an advocate for sites and patients and is excited about making it easier to access clinical trials across the globe.
Brothers Tom & Chris Hannaway founded Infinite Session, an alcohol-free beer brand, in London in 2017. As alcohol drinkers, they were looking for lower-strength beer options that actually tasted like beer they found in their favourite pubs and bars in East London.
Since launching, Infinite Session has sold millions of cans of their flagship IPA beer, in many countries around the world, and won several awards, including in alcoholic beer categories, with their core team of two. Infinite Session has recently launched Brisk, a low calorie & 3.3% ABV Light Lager brand.
Brothers Tom & Chris Hannaway founded Infinite Session, an alcohol-free beer brand, in London in 2017. As alcohol drinkers, they were looking for lower-strength beer options that actually tasted like beer they found in their favourite pubs and bars in East London.
Since launching, Infinite Session has sold millions of cans of their flagship IPA beer, in many countries around the world, and won several awards, including in alcoholic beer categories, with their core team of two. Infinite Session has recently launched Brisk, a low calorie & 3.3% ABV Light Lager brand.
Waldemar is a seasoned professional with over a decade of experience in the field of electronics protection and will share fresh insights around EMI protection during the panel discussion. His current role is the Global Product Manager for the nVent SCHROFF electromechanical offering. Waldemar’s background includes an MBA from Stuttgart Media University and a Bachelor’s of Science in Engineering and Business Administration from Pforzheim University.
Railway Olivier provides over 25 years of mechanical design and engineering expertise. From engineering to global program management and key account management, Olivier will share invaluable insights from his extensive experience, promising an enlightening session filled with practical knowledge and industry best practices Olivier studied at the Higher Institute of Mechanical Production and Engineering in France.
Provide delivery oversight for the General Medicine book of business for ICONs Biotech customers, with a primary specialization in Cardiovascular, Metabolic, Hepatology-MASH, and GI.
20 years industry experience, with 11 years in the companies that comprise of ICON, with extensive experience in building operational strategy throughout the people, process, vision, and infrastructure required to successfully to deliver trials across my areas of specialization
Ash Noah – CPA, FCMA, CGMA, is VP and Managing Director of Learning, Education and Development, at the Association of International Certified Professional Accountants.
In this position, Ash leads the Research, Examinations and Learning product development for the
Management Accounting Unit.
Ash works closely with CFOs and Business Finance Leaders globally, identifying the trends that are
impacting practitioners, businesses and the profession in order to ensure that the Association’s Finance
Competency Framework, Syllabus, Examinations and Learning solutions remain effective and are
producing competencies to operate and remain relevant in the practice of Business Finance.
Ash was formerly the CFO of the International Unit of TNT, A global express logistics provider and has
led finance transformation in teams across 45 countries. He is a Chartered Global Management
Accountant (CGMA), licensed US CPA and member of the American Institute of CPA’s (AICPA). He is also a Fellow of the Chartered Institute of Management Accountants (CIMA).
Ash has a passion for flying and is an avid aviator.
